The serologic decoy receptor 3 (DcR3) levels are associated with slower disease progression in HIV-1/AIDS patients

Yu Ting Lin, Chia Hung Yen, Heng Li Chen, Yi Jen Liao, I. Feng Lin, Marcelo Chen, Yu Ching Lan, Shao Yuan Chuang, Shie Liang Hsieh, Yi Ming Arthur Chen

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background/Purpose: The decoy receptor 3 (DcR3) is a member of the tumor necrosis factor receptor (TNFR) super-family. It counteracts the biological effects of Fas ligands and inhibits apoptosis. The goals of this study were to understand the associations between serologic DcR3 (sDcR3) levels and different human immunodeficiency virus type 1 (HIV-1) subtypes, as well as the AIDS disease progression. Methods: Serum samples from 61 HIV/AIDS patients, who had been followed up every 6 months for 3 years, were collected. sDcR3 levels were quantified using an enzyme immunoassay (EIA). Results: The sDcR3 levels in patients with HIV-1 subtype B were significantly higher than those in patients infected with subtype CRF01_AE (. p

Original languageEnglish
Pages (from-to)498-503
Number of pages6
JournalJournal of the Formosan Medical Association = Taiwan yi zhi
Volume114
Issue number6
DOIs
Publication statusPublished - Jun 1 2015

Fingerprint

Disease Progression
HIV-1
Acquired Immunodeficiency Syndrome
Fas Ligand Protein
Tumor Necrosis Factor Receptors
Immunoenzyme Techniques
HIV
Apoptosis
Serum

Keywords

  • Decoy receptor 3 (DcR3)
  • Disease progression
  • HIV/AIDS
  • Subtype

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The serologic decoy receptor 3 (DcR3) levels are associated with slower disease progression in HIV-1/AIDS patients. / Lin, Yu Ting; Yen, Chia Hung; Chen, Heng Li; Liao, Yi Jen; Lin, I. Feng; Chen, Marcelo; Lan, Yu Ching; Chuang, Shao Yuan; Hsieh, Shie Liang; Chen, Yi Ming Arthur.

In: Journal of the Formosan Medical Association = Taiwan yi zhi, Vol. 114, No. 6, 01.06.2015, p. 498-503.

Research output: Contribution to journalArticle

Lin, Yu Ting ; Yen, Chia Hung ; Chen, Heng Li ; Liao, Yi Jen ; Lin, I. Feng ; Chen, Marcelo ; Lan, Yu Ching ; Chuang, Shao Yuan ; Hsieh, Shie Liang ; Chen, Yi Ming Arthur. / The serologic decoy receptor 3 (DcR3) levels are associated with slower disease progression in HIV-1/AIDS patients. In: Journal of the Formosan Medical Association = Taiwan yi zhi. 2015 ; Vol. 114, No. 6. pp. 498-503.
@article{eea38f4d772040fca1e29594ff49e213,
title = "The serologic decoy receptor 3 (DcR3) levels are associated with slower disease progression in HIV-1/AIDS patients",
abstract = "Background/Purpose: The decoy receptor 3 (DcR3) is a member of the tumor necrosis factor receptor (TNFR) super-family. It counteracts the biological effects of Fas ligands and inhibits apoptosis. The goals of this study were to understand the associations between serologic DcR3 (sDcR3) levels and different human immunodeficiency virus type 1 (HIV-1) subtypes, as well as the AIDS disease progression. Methods: Serum samples from 61 HIV/AIDS patients, who had been followed up every 6 months for 3 years, were collected. sDcR3 levels were quantified using an enzyme immunoassay (EIA). Results: The sDcR3 levels in patients with HIV-1 subtype B were significantly higher than those in patients infected with subtype CRF01_AE (. p",
keywords = "Decoy receptor 3 (DcR3), Disease progression, HIV/AIDS, Subtype",
author = "Lin, {Yu Ting} and Yen, {Chia Hung} and Chen, {Heng Li} and Liao, {Yi Jen} and Lin, {I. Feng} and Marcelo Chen and Lan, {Yu Ching} and Chuang, {Shao Yuan} and Hsieh, {Shie Liang} and Chen, {Yi Ming Arthur}",
year = "2015",
month = "6",
day = "1",
doi = "10.1016/j.jfma.2013.01.007",
language = "English",
volume = "114",
pages = "498--503",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
publisher = "Elsevier Science Publishers B.V.",
number = "6",

}

TY - JOUR

T1 - The serologic decoy receptor 3 (DcR3) levels are associated with slower disease progression in HIV-1/AIDS patients

AU - Lin, Yu Ting

AU - Yen, Chia Hung

AU - Chen, Heng Li

AU - Liao, Yi Jen

AU - Lin, I. Feng

AU - Chen, Marcelo

AU - Lan, Yu Ching

AU - Chuang, Shao Yuan

AU - Hsieh, Shie Liang

AU - Chen, Yi Ming Arthur

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Background/Purpose: The decoy receptor 3 (DcR3) is a member of the tumor necrosis factor receptor (TNFR) super-family. It counteracts the biological effects of Fas ligands and inhibits apoptosis. The goals of this study were to understand the associations between serologic DcR3 (sDcR3) levels and different human immunodeficiency virus type 1 (HIV-1) subtypes, as well as the AIDS disease progression. Methods: Serum samples from 61 HIV/AIDS patients, who had been followed up every 6 months for 3 years, were collected. sDcR3 levels were quantified using an enzyme immunoassay (EIA). Results: The sDcR3 levels in patients with HIV-1 subtype B were significantly higher than those in patients infected with subtype CRF01_AE (. p

AB - Background/Purpose: The decoy receptor 3 (DcR3) is a member of the tumor necrosis factor receptor (TNFR) super-family. It counteracts the biological effects of Fas ligands and inhibits apoptosis. The goals of this study were to understand the associations between serologic DcR3 (sDcR3) levels and different human immunodeficiency virus type 1 (HIV-1) subtypes, as well as the AIDS disease progression. Methods: Serum samples from 61 HIV/AIDS patients, who had been followed up every 6 months for 3 years, were collected. sDcR3 levels were quantified using an enzyme immunoassay (EIA). Results: The sDcR3 levels in patients with HIV-1 subtype B were significantly higher than those in patients infected with subtype CRF01_AE (. p

KW - Decoy receptor 3 (DcR3)

KW - Disease progression

KW - HIV/AIDS

KW - Subtype

UR - http://www.scopus.com/inward/record.url?scp=84930418495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930418495&partnerID=8YFLogxK

U2 - 10.1016/j.jfma.2013.01.007

DO - 10.1016/j.jfma.2013.01.007

M3 - Article

C2 - 26062966

AN - SCOPUS:84930418495

VL - 114

SP - 498

EP - 503

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

SN - 0929-6646

IS - 6

ER -